AQR Capital Management
OMED

AQR Capital Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

AQR Capital Management’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-12,100
Closed -$263K – 2576
2014
Q4 		$263K Buy
+12,100
New +$248K ﹤0.01% 2261

Other funds holding OMED

ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Apex Capital Orinda, California $938M AUM 4.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management's OMED Position: Q1 2015 in Review

AQR Capital Management sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q1 2015, closing a stake of 12,100 shares — an estimated $263K sold.

AQR Capital Management first reported a position in OMED in Q4 2014 and held it in 1 quarter. The position peaked at $263K in Q4 2014. 78 funds tracked by Wall St. Rank hold OMED as of Q1 2015.

  • AQR Capital Management reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • AQR Capital Management sold 12,100 OncoMed Pharmaceuticals, Inc. shares in Q1 2015, an estimated $263K.
  • AQR Capital Management first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2014 and held it in 1 quarter.
  • AQR Capital Management's OncoMed Pharmaceuticals, Inc. position peaked at $263K in Q4 2014.
  • 78 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q1 2015.

Based on AQR Capital Management's 13F filing for Q1 2015, filed 15 May 2015.